Michael Ombrello։ Decoding How Autoantibodies Cause Disease
Michael Ombrello, Tenure-Track Investigator at National Institute of Arthritis and Musculoskeletal and Skin Diseases, shared Teerin Liewluck’s post on LinkedIn:
”Identifying autoantibodies is descriptive.
Identifying a new mechanism through which autoantibodies cause disease in an epitope-specific manner is revolutionary.
Congratulations to Iago Pinal-Fernandez, Andrew Mammen and colleagues!”
Teerin Liewluck, Professor of Neurology at Mayo Clinic Rochester, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Annals of the Rheumatic Diseases, adding:
”Hot Off the Press:
Excited to be part of this outstanding collaborative work led by Iago Pinal-Fernandez and Andrew Mammen.
This paper provides important insights into one of the central questions in myositis:
How do myositis autoantibodies reach their target antigens and drive disease?
Congratulations to everyone involved in this exciting work!!!”
Title: Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies
Authors: Iago Pinal-Fernandez, Katherine Pak, Maria Casal-Dominguez, Sandra Muñoz-Braceras, Gustaf Wigerblad, Stefania Dell’Orso, Faiza Naz, Shamima Islam, Gustavo Gutierrez-Cruz, Travis B. Kinder, S. Amara Ogbonnaya-Whittlesey, Andreu Fernández-Codina, Margherita Giannini, Benjamin Ellezam, Gilles Laverny, Valentine Gilbart, Océane Landon-Cardinal, Marie Hudson, Yves Troyanov, Davide Randazzo, Aster Kenea, Ana Matas-Garcia, Gloria Garrabou, Iban Aldecoa, Gabriela Ailen-Caballero, Albert Gil-Vila, Ernesto Trallero, Margherita Milone, Teerin Liewluck, Elie Naddaf, Gerard Espinosa, Carmen Pilar Simeon-Aznar, Alfredo Guillen-Del-Castillo, Corinna Preusse, Felix Kleefeld, Nikolas Bublitz, Werner Stenzel, Alain Meyer, Janet E. Pope, Albert Selva-O’Callaghan, Jose C Milisenda, Andrew L. Mammen.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice